PRISMASOL BGK2/3.5 5.4 g/L

PRISMASOL BGK2/3.5 5.4 g/L is an intravenous injection containing calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, and sodium bicarbonate. It is designed to support electrolyte balance and fluid replacement in clinical settings. This product is manufactured by Vantive US Healthcare LLC.

PRISMASOL BGK2/3.5 5.4 g/L is used to replenish essential electrolytes and fluids in the body. It is commonly administered to patients who require intravenous fluid therapy to maintain proper hydration and electrolyte levels. This solution is particularly useful in situations where oral intake is not feasible or sufficient.

The effects of PRISMASOL BGK2/3.5 5.4 g/L include the restoration of electrolyte balance and hydration. Patients may experience improved energy levels and overall well-being as the solution helps to maintain the body's fluid and electrolyte equilibrium. Common effects include a sense of rehydration and stabilization of vital electrolytes.

PRISMASOL BGK2/3.5 5.4 g/L should be administered under medical supervision. It is important to follow the prescribed dosage and administration guidelines to avoid potential side effects. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

PRISMASOL BGK2/3.5 5.4 g/L may interact with other medications or substances. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain dietary supplements may also affect the efficacy of this solution.